‹ Screener

AUNA S.A.

AUNA · Services-Offices & Clinics of Doctors of Medicine · EDGAR filings ↗

Reference price $4.15 — last insider purchase, 2026-05-29 (estimated from the dated SEC Form 4 price — not a live quote)

Grade

B72

Leading Latin American oncology/hospital operator with strong operating margins and cash conversion, but levered and exposed to emerging-market risk.

Strengths

Risks

Notable findings

Key metrics

Gross margin
39.3%
Operating margin
17.9%
Net margin
2.8%
Return on equity
7.6%
Return on assets
1.8%
ROIC
11.8%
Revenue growth (QoQ)
13.2%
Debt / equity
2.2×
Interest coverage
1.4×
Current ratio
0.9×
Free cash flow
$158M
Tangible book value
-$36M
Cash & investments
$64M

Insider transactions · last 18 months

DateInsiderTypeSharesPrice
2026-05-29Zamora Leon JesusBuy6.4K$4.15
2026-05-28Zamora Leon JesusBuy9.2K$4.17
2026-05-28Wilton JohnSell18K$4.17
2026-05-27Zamora Leon JesusBuy23K$4.20
2026-05-26Zamora Leon JesusBuy8.7K$4.24
2026-05-26Zamora Leon JesusBuy30K$4.39
2026-05-20Zamora Leon JesusBuy5.8K$4.39

All non-derivative Form 4 activity (SEC), newest first.

Recent filings

FormFiledPeriodAccession
20-F2026-04-222025-12-310001193125-26-168210 ↗
20-F2025-04-102024-12-310001193125-25-078014 ↗